Nations Financial Group Inc. IA ADV Makes New Investment in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) (2024)

Nations Financial Group Inc. IA ADV acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 7,695 shares of the pharmacy operator’s stock, valued at approximately $201,000.

Several other institutional investors and hedge funds have also modified their holdings of WBA. New York Life Investment Management LLC boosted its stake in shares of Walgreens Boots Alliance by 0.4% during the 3rd quarter. New York Life Investment Management LLC now owns 114,506 shares of the pharmacy operator’s stock worth $2,547,000 after acquiring an additional 499 shares in the last quarter. Fulton Bank N.A. increased its position in shares of Walgreens Boots Alliance by 0.5% in the fourth quarter. Fulton Bank N.A. now owns 107,071 shares of the pharmacy operator’s stock valued at $2,796,000 after buying an additional 523 shares in the last quarter. Insight Folios Inc raised its stake in shares of Walgreens Boots Alliance by 5.8% during the 4th quarter. Insight Folios Inc now owns 9,640 shares of the pharmacy operator’s stock worth $252,000 after buying an additional 525 shares during the period. Pinnacle Financial Partners Inc lifted its position in shares of Walgreens Boots Alliance by 4.9% during the 4th quarter. Pinnacle Financial Partners Inc now owns 11,866 shares of the pharmacy operator’s stock valued at $310,000 after buying an additional 555 shares in the last quarter. Finally, Westpac Banking Corp grew its stake in Walgreens Boots Alliance by 10.1% in the 4th quarter. Westpac Banking Corp now owns 6,100 shares of the pharmacy operator’s stock valued at $159,000 after acquiring an additional 560 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 4.1 %

Shares of WBA opened at $15.38 on Wednesday. The company’s 50-day moving average price is $18.26 and its 200 day moving average price is $21.08. Walgreens Boots Alliance, Inc. has a 12-month low of $15.34 and a 12-month high of $32.89. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The firm has a market cap of $13.27 billion, a P/E ratio of -2.20, a price-to-earnings-growth ratio of 1.00 and a beta of 0.80.

Want More Great Investing Ideas?

Walgreens Boots Alliance Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st will be paid a $0.25 dividend. The ex-dividend date is Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 6.50%. Walgreens Boots Alliance’s payout ratio is presently -14.29%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Leerink Partnrs reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. UBS Group cut their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, April 3rd. Truist Financial reaffirmed a “hold” rating and issued a $25.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. Deutsche Bank Aktiengesellschaft reduced their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research note on Wednesday, April 3rd. Finally, Raymond James reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $24.36.

Read Our Latest Research Report on WBA

Insider Buying and Selling

In other news, CFO Manmohan Mahajan bought 6,000 shares of the company’s stock in a transaction on Tuesday, April 2nd. The stock was bought at an average cost of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now directly owns 166,969 shares in the company, valued at approximately $3,235,859.22. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, Director Inderpal S. Bhandari acquired 3,000 shares of the business’s stock in a transaction dated Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Manmohan Mahajan acquired 6,000 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, April 2nd. The stock was bought at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is owned by corporate insiders.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.